Insights on a new sulfonamide chalcone with potential antineoplastic application

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Computational Chemistry

Background:

• Chalcones, precursors to flavonoids, exhibit diverse biological activities.
• Synthetic chalcone derivatives are of significant academic and industrial interest.
• The development of novel antineoplastic agents remains a critical research area.

Purpose of the Study:

• To synthesize and structurally characterize a novel sulfonamide chalcone.
• To evaluate the potential antineoplastic application of the synthesized compound.
• To investigate the in silico binding interactions with the Epidermal Growth Factor Receptor (EGFR).

Main Methods:

• Synthesis of the sulfonamide chalcone: 1-Benzenesulfonyl-3-(4-bromobenzylidene)-2-(2-chlorophenyl)-2,3-dihydro-1H-quinolin-4-one.
• Extensive structural analysis of the synthesized compound.
• In silico docking studies to assess binding affinity and interactions with EGFR.

Main Results:

• Successful synthesis and structural elucidation of the target sulfonamide chalcone.
• In silico experiments demonstrated favorable binding within the EGFR ligand-binding site.
• Seven specific micro-alkyl binding energy interactions were identified.
• Kinetic stability and pharmacophoric analysis indicated potential antagonist activity against EGFR.

Conclusions:

• The synthesized sulfonamide chalcone possesses structural characteristics suitable for antineoplastic activity.
• Its interaction profile with EGFR suggests potential as an EGFR antagonist.
• Further investigation is warranted to explore its therapeutic efficacy.